Clinical Trial

Assessing the Safety of an IGY Supplement on the Gut Microbiome

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 22, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is to evaluate whether Muno-IgY is effective in enhancing immune health among adults over a six week period.
Trial Details
NCT Number NCT06702280
Lead Sponsor Nimble Science Ltd.
Collaborators: IGY Immune Technologies & Life Sciences Inc.
Conditions Healthy, Microbiome
Enrollment 20 participants
Start Date 2025-02
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-11-22